《中国抗癌协会多发肺癌诊疗多学科专家共识》解读

Interpretation of the Multidisciplinary Expert Consensus on Diagnosi and Treatment of Multiple Lung Cancers by the Chinese Anti-Cancer Association

  • 摘要: 随着低剂量CT的广泛应用,多发肺癌(multiple lung cancers, MLCs)的检出率呈逐渐上升趋势,其诊断及治疗已成为胸外科及肿瘤科临床实践中的重要挑战。2025年4月,中国抗癌协会肺癌专业委员会组织相关领域国内外多学科专家,发布了首版针对多发肺癌诊疗的多学科专家共识,对多发肺癌的诊断体系、分子评估策略、手术及非手术治疗提出了系统性建议。本文针对该共识的核心内容进行详细解读,并结合领域内最新研究进展,深入探讨多发肺癌的发病机制、精准诊断策略及个体化治疗路径,以期为临床实践提供更为全面的参考依据。

     

    Abstract: With the widespread application of low-dose computed tomography (CT), the detection rate of multiple lung cancers (MLCs) is gradually increasing. The diagnosis and treatment of MLCs have become a major challenge in clinical practice in thoracic surgery and oncology. In April 2025, the Lung Cancer Professional Committee of the China Anti-Cancer Association (CACA) organized multidisciplinary experts from both domestic and international fields to release the first edition of the CACA Expert Consensus on the Diagnosis and Treatment of Multiple Lung Cancers, providing systematic recommendations for the diagnostic system, molecular assessment strategies, and surgical and non-surgical management of MLCs. This article provides a detailed interpretation of the core content of this consensus and, by incorporating the latest research progress in the field, delves into the pathogenesis, precise diagnostic strategies, and individualized treatment pathways for multiple lung cancers, aiming to offer a more comprehensive reference for clinical practice.

     

/

返回文章
返回